CD4 and breast carcinoma: This encouraging result obtained on ALC or T cell counts led the Blay/Ray-Coquard team to further document CD4 T cell counts in various populations of cancer patients, including breast cancer, and to further explore the diversity of the TCR repertoire in collaboration with ImmunID Technologies.